209 related articles for article (PubMed ID: 31285544)
21. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
[TBL] [Abstract][Full Text] [Related]
22. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.
Donati G; Peddigari S; Mercer CA; Thomas G
Cell Rep; 2013 Jul; 4(1):87-98. PubMed ID: 23831031
[TBL] [Abstract][Full Text] [Related]
23. Autophagy inhibition switches low-dose camptothecin-induced premature senescence to apoptosis in human colorectal cancer cells.
Zhang JW; Zhang SS; Song JR; Sun K; Zong C; Zhao QD; Liu WT; Li R; Wu MC; Wei LX
Biochem Pharmacol; 2014 Aug; 90(3):265-75. PubMed ID: 24858802
[TBL] [Abstract][Full Text] [Related]
24. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
25. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
[TBL] [Abstract][Full Text] [Related]
26. In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.
Pradines B; Tall A; Parzy D; Spiegel A; Fusai T; Hienne R; Trape JF; Doury JC
J Antimicrob Chemother; 1998 Sep; 42(3):333-9. PubMed ID: 9786473
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of post-transcriptional steps in ribosome biogenesis confers cytoprotection against chemotherapeutic agents in a p53-dependent manner.
Sapio RT; Nezdyur AN; Krevetski M; Anikin L; Manna VJ; Minkovsky N; Pestov DG
Sci Rep; 2017 Aug; 7(1):9041. PubMed ID: 28831158
[TBL] [Abstract][Full Text] [Related]
28. The Ribosome Biogenesis-Cancer Connection.
Penzo M; Montanaro L; Treré D; Derenzini M
Cells; 2019 Jan; 8(1):. PubMed ID: 30650663
[TBL] [Abstract][Full Text] [Related]
29. Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.
Derenzini E; Rossi A; Treré D
J Hematol Oncol; 2018 May; 11(1):75. PubMed ID: 29855342
[TBL] [Abstract][Full Text] [Related]
30. Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.
Zhang ZL; Zhao CL; Chen Q; Xu K; Qiao X; Xu JY
Eur J Med Chem; 2018 Jul; 155():434-444. PubMed ID: 29908438
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance.
El Hassouni B; Sarkisjan D; Vos JC; Giovannetti E; Peters GJ
Curr Med Chem; 2019; 26(33):6020-6032. PubMed ID: 30501594
[TBL] [Abstract][Full Text] [Related]
32. Palladium (II) Complex Enhances ROS-Dependent Apoptotic Effects via Autophagy Inhibition and Disruption of Multiple Signaling Pathways in Colorectal Cancer Cells.
Aydinlik S; Erkisa M; Ari F; Celikler S; Ulukaya E
Anticancer Agents Med Chem; 2021; 21(10):1284-1291. PubMed ID: 32990544
[TBL] [Abstract][Full Text] [Related]
33. The antimalarial drug amodiaquine possesses anti-ZIKA virus activities.
Han Y; Mesplède T; Xu H; Quan Y; Wainberg MA
J Med Virol; 2018 May; 90(5):796-802. PubMed ID: 29315671
[TBL] [Abstract][Full Text] [Related]
34. Novel anti-adipogenic activity of anti-malarial amodiaquine through suppression of PPARγ activity.
Kim TH; Kim HK; Hwang ES
Arch Pharm Res; 2017 Nov; 40(11):1336-1343. PubMed ID: 29071567
[TBL] [Abstract][Full Text] [Related]
35. p53 localizes to intranucleolar regions distinct from the ribosome production compartments.
Krüger T; Scheer U
J Cell Sci; 2010 Apr; 123(Pt 8):1203-8. PubMed ID: 20332106
[TBL] [Abstract][Full Text] [Related]
36. Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis.
Kusnadi EP; Trigos AS; Cullinane C; Goode DL; Larsson O; Devlin JR; Chan KT; De Souza DP; McConville MJ; McArthur GA; Thomas G; Sanij E; Poortinga G; Hannan RD; Hannan KM; Kang J; Pearson RB
EMBO J; 2020 Nov; 39(21):e105111. PubMed ID: 32945574
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
Brighenti E; Calabrese C; Liguori G; Giannone FA; Trerè D; Montanaro L; Derenzini M
Oncogene; 2014 Aug; 33(35):4396-406. PubMed ID: 24531714
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
Choi JH; Yoon JS; Won YW; Park BB; Lee YY
APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
[TBL] [Abstract][Full Text] [Related]
39. Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.
Rhodes EG; Ball J; Franklin IM
Br Med J (Clin Res Ed); 1986 Mar; 292(6522):717-8. PubMed ID: 3082409
[TBL] [Abstract][Full Text] [Related]
40. Effective targeting of RNA polymerase I in treatment-resistant prostate cancer.
Low JY; Sirajuddin P; Moubarek M; Agarwal S; Rege A; Guner G; Liu H; Yang Z; De Marzo AM; Bieberich C; Laiho M
Prostate; 2019 Dec; 79(16):1837-1851. PubMed ID: 31524299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
